Delphia
PrivateLast Round
Series A
May 2, 2024
Total Funding Raised
$67M
Company Overview
Delphia is a biotechnology company focused on developing innovative cancer therapeutics that selectively over-activate specific cancer-linked cell signaling pathways to eliminate tumor cells and improve patient outcomes.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Data as a Service, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Delphia Comps
Public and private peers based on sector, stage, and business model.
Delphia Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 2, 2024 |
Delphia Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GV | Series A, Seed |
| Nextech Invest | Series A |
| Polaris Partners | Series A |
| Polaris Innovation Fund | Series A |
| Alexandria Venture Investments | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 9, 2025
Steve Kelsey, M.D. appointed to the board of directors.
- May 28, 2025
Reza Mazhari appointed as the new chief business officer.
Delphia Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Delphia's valuation, stock price, and market status.
